# Needle-Free Subcutaneous Injector and Conventional Intramuscular Injection of Mecobalamin in Diabetes Peripheral Neuropathy

> **NCT06400888** · NA · NOT_YET_RECRUITING · sponsor: **Peking University Third Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Diabetic Peripheral Neuropathy

## Interventions

- **OTHER:** needle-free subcutaneous injector for Mecbl
- **OTHER:** intramuscular injection of Mecbl

## Key facts

- **NCT ID:** NCT06400888
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-05-30
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06400888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06400888, "Needle-Free Subcutaneous Injector and Conventional Intramuscular Injection of Mecobalamin in Diabetes Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06400888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*